MedTrace Logo

Stereotactic Radiosurgery for Soft Tissue Sarcoma

NCT02706171 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2024-03-15

No results posted yet for this study

Summary

This study is evaluating treatment with CyberKnife for soft tissue sarcomas.

Conditions

  • Soft Tissue Sarcoma

Interventions

RADIATION

CyberKnife

Sponsors & Collaborators

  • The Cooper Health System

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02706171 on ClinicalTrials.gov